Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82b8ce8e71df155d570d141ceb42fdb0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db6d3b22616eb533d2b0badbbf91fca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08752abdfead4c7aa8d764b18eee04d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5042666db9488f7c4bcca31730638433 |
publicationDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2693761-T3 |
titleOfInvention |
Peptide compositions |
abstract |
An isolated polypeptide selected from: Ac-Arg-cycle [Cys-D-Ala-Asn-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 7); Ac-Arg-cycle [Cys-D-Ala-Gln-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 8); Ac-Arg-cycle [Cys-D-Ala-Pro-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 2); Ac-Arg-cycle [hCys-D-Gln-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 51); Ac-Arg-cycle [hCys-Ala-D-Phe-Arg-Trp-Pen] -NH2 (SEQ ID NO: 52); Ac-Arg-cycle [Cys-Val-Gln-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 57); Ac-Arg-cycle [Cys-D-Val-Gln-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 11); Ac-TzAla-cycle [Cys-Ala-Gln-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 59); Ac-Arg-cycle [Cys-D-Ala-Trp-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 9); Ac-Arg-cycle [Cys-D-Ala-Tyr-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 39); Ac-Arg-cycle [Cys-D-Ala-Pro-D-Phe (p-F) -Arg-Trp-Cys] -NH2 (SEQ ID NO: 4); Ac-Arg-cycle [hCys-Ala-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 15); Ac-Arg-cycle [hCys-D-Ala-D-Phe-Arg-Trp-Cys] -NH2 (SEQ ID NO: 14); or Ac-Arg-cycle [hCys-D-Ala-D-Phe-Arg-Trp-Pen] -NH2 (SEQ ID NO: 45), or a pharmaceutically acceptable salt thereof. |
priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |